SCHEMBL5797737

SCHEMBL5797737

CCn1c2ccc(F)cc2c2cc(CO)ccc21

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.54
▸ HPGD P15428 2/20 0.54
▸ ALDH1A1 P00352 2/20 0.54
▸ TSHR P16473 1/20 0.54
▸ HSD17B10 Q99714 1/20 0.54
▸ RORC P51449 1/20 0.49
▸ PGR P06401 1/20 0.47
▸ MAPT P10636 4/20 0.47
▸ MAPK1 P28482 2/20 0.47
▸ LMNA P02545 1/20 0.47
▸ POLB P06746 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ CRY2 Q49AN0 9/20 0.44
▸ PER2 O15055 8/20 0.44
▸ CRY1 Q16526 7/20 0.43
▸ TP53 P04637 2/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5163862 0.90 KDM4E (0.64) KDM4EHPGDALDH1A1TSHRHSD17B10
SCHEMBL8134208 0.86 KDM4E (0.57) KDM4EHPGDALDH1A1TSHRHSD17B10
SCHEMBL5794680 0.82 KDM4E (0.55) KDM4EHPGDALDH1A1TSHRHSD17B10
SCHEMBL4849333 0.82 KDM4E (0.67) KDM4EHPGDALDH1A1TSHRHSD17B10
SCHEMBL5798005 0.81 PTGER4 (0.57) KDM4EHPGDALDH1A1TSHRHSD17B10
SCHEMBL541218 0.78 PTGER4 (0.59) KDM4EHPGDALDH1A1TSHRHSD17B10
SCHEMBL20631884 0.78 KDM4E (0.50) KDM4EHPGDALDH1A1TSHRHSD17B10
SCHEMBL29643189 0.78 MAPT (0.65) KDM4EHPGDALDH1A1TSHRHSD17B10
SCHEMBL15868578 0.78 MAPT (0.65) KDM4EHPGDALDH1A1TSHRHSD17B10
SCHEMBL7974817 0.75 MAPT (0.68) KDM4EHPGDALDH1A1TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006030124-A1 CONDENSED PYRAZOLE DERIVATIVES, PREPARATION METHOD THEREOF AND THERAPEUTIC USE OF SAME SANOFI-AVENTIS (FR) 2006-03-23 — — WO disclosed
WO-2006012310-A2 CARBAZOLE DERIVATIVES FOR TREATING POLYCYSTIC KIDNEY DISEASE GENZYME CORPORATION (US) 2006-02-02 — — WO disclosed
Send feedback